Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Associate Professor and UFG, Brazil

Assoc. Prof. Dr. Ricardo Menegatti is an Associate Professor at the Faculty of Pharmacy, Federal University of Goiás (UFG), Brazil. His academic journey began with a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC), followed by a Master’s degree in Chemistry and a Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ). His doctoral research focused on the design, synthesis, and pharmacological evaluation of novel neuroactive drug prototypes. Dr. Menegatti’s expertise spans various aspects of medicinal chemistry, including the development of new pharmacological agents, medicinal chemistry, and pharmaceutical analysis. He has been actively involved in teaching and research since joining UFG in 2006, where he has contributed to the development of courses in medicinal chemistry, pharmaceutical analysis, and organic chemistry. His work also includes extensive contributions to the university’s extension activities, such as coordinating workshops and seminars on pharmaceutical chemistry. Dr. Menegatti has a robust record of publications and presentations in his field, and his research interests primarily revolve around the synthesis of novel pharmacological agents and the application of advanced chemical techniques in drug development.

Profile
Education

Dr. Ricardo Menegatti holds a distinguished educational background in the field of pharmacy and chemistry. He earned his Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC) in 1998, where his research focused on leprosy. He then pursued advanced studies at the Federal University of Rio de Janeiro (UFRJ), obtaining a Master’s degree in Chemistry in 2001. His master’s research, under the guidance of Eliezer Jesus Barreiro, involved the design, synthesis, and pharmacological evaluation of new antipsychotic drug candidates, specifically targeting schizophrenia. Dr. Menegatti further advanced his expertise by completing a Ph.D. in Chemistry at UFRJ in 2005, focusing on the planning, synthesis, and pharmacological assessment of neuroactive drug prototypes, particularly in the areas of GABA, hypnotics, and analgesics. His doctoral research, also mentored by Eliezer J. Barreiro, was supported by the National Council for Scientific and Technological Development (CNPq), reflecting his commitment to advancing pharmaceutical sciences.

Professional Experience

Dr. Ricardo Menegatti is a seasoned academic and researcher with a strong background in pharmaceutical chemistry and medicinal compounds. He holds a Doctorate in Chemistry from the Federal University of Rio de Janeiro, where his research focused on the design, synthesis, and pharmacological evaluation of neuroactive drug prototypes. Dr. Menegatti currently serves as a Professor at the Faculty of Pharmacy, Federal University of Goiás, Brazil, where he has been a dedicated faculty member since 2006. His expertise lies in planning and synthesizing biologically active compounds, particularly those targeting neuroactive and antipsychotic pathways. In addition to his teaching responsibilities, Dr. Menegatti is actively involved in graduate-level mentoring, guiding students in the Biological Sciences postgraduate program. His contributions extend to organizing workshops, coordinating seminars, and participating in extension activities, reflecting his commitment to advancing pharmaceutical education and research.

Research Interests

Dr. Ricardo Menegatti’s research interests lie at the intersection of pharmaceutical chemistry and medicinal chemistry, with a particular focus on the design, synthesis, and pharmacological evaluation of biologically active compounds. His work primarily revolves around the development of neuroactive drug prototypes, targeting the GABAergic system to explore potential treatments for neurological disorders such as schizophrenia, anxiety, and sleep disorders. Additionally, Dr. Menegatti is engaged in the discovery of new analgesic and antipsychotic agents, leveraging his expertise in molecular modeling and structure-activity relationships (SAR) to enhance drug efficacy and safety. His research also extends to the use of solid-phase synthesis and enzymatic catalysis in drug development, aiming to innovate in the creation of new therapeutic agents. Through his work, Dr. Menegatti contributes to the advancement of medicinal chemistry, striving to address critical challenges in the treatment of mental health disorders.

Awards and Recognition

Dr. Menegatti’s academic and research excellence has been recognized through various awards and honors throughout his career. As a recipient of scholarships from the National Council for Scientific and Technological Development (CNPq) in Brazil, he has demonstrated a strong commitment to advancing scientific knowledge. His leadership in organizing workshops and seminars further highlights his contributions to the academic community, earning him recognition among his peers and students.

Conclusion

Dr. Ricardo Menegatti’s extensive research contributions in medicinal chemistry, particularly in the development of neuroactive and antipsychotic drug candidates, make him a strong candidate for the Research for Best Researcher Award. His work has a significant geographic impact, with potential applications in global healthcare. While his research is primarily focused on pharmaceutical sciences, its implications extend to broader areas such as infectious diseases. Dr. Menegatti’s collaborative efforts, applied research, and academic leadership further solidify his suitability for this prestigious award.

Publications Top Notes

LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety Treatment

  • Journal: International Journal of Molecular Sciences
  • Date: September 26, 2023
  • DOI: 10.3390/ijms241914575

Bioanalytical LC-QTOF/MS Method for a N-phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies

Antileishmanial Activity of the Chalcone Derivative LQFM064 Associated with Reduced Fluidity in the Parasite Membrane as Assessed by EPR Spectroscopy

Toxico-Pharmacological Evaluations of the Small-Molecule LQFM166: Inducer of Apoptosis and MDM2 Antagonist

 

Prof. AHM Nurun Nabi | Genetic Analyses | Outstanding Scientist Award

Posted on by ScienceFather

Prof. AHM Nurun Nabi | Genetic Analyses | Outstanding Scientist Award

Professor at Genetic Analyses, University of Dhaka, Bangladesh

Professor A.H.M. Nurun Nabi is a distinguished scholar in the Department of Biochemistry and Molecular Biology at the University of Dhaka, Bangladesh. His expertise lies in protein expression, protein-protein interactions, and cell culture techniques. He has conducted extensive research on health hazards in various occupational settings and arsenic toxicity in the Bangladeshi population. Prof. Nabi has received several scholarships and awards for his contributions to biochemistry research.

Professional Profiles:

Academic Qualifications:

Prof. AHM Nurun Nabi completed his Doctor of Philosophy in Biochemistry from the laboratory of Animal Biochemistry, United Graduate School of Agricultural Science, Gifu University, Japan, in 2006. Prior to this, he obtained a Master of Philosophy in Biochemistry from the Department of Biochemistry and Molecular Biology, University of Dhaka, Bangladesh, in 2000. His academic journey began with a Master of Science in Biochemistry from the same department at the University of Dhaka in 1996, where he graduated with First class honors. He also holds a Bachelor of Science in Biochemistry from the University of Dhaka, earned in 1995 with First class honors. Prof. AHM Nurun Nabi’s educational foundation includes a Higher Secondary Certificate in Science from Rajshahi College, Rajshahi, in 1992, and a Secondary School Certificate in Science from Rajshahi Collegiate School, Rajshahi, in 1990, both achieved with First division distinctions.

Professional:

Prof. AHM Nurun Nabi has a rich history of professional attachments in the field of biochemistry and molecular biology. He has been serving as a Professor in the Department of Biochemistry and Molecular Biology at the University of Dhaka, Bangladesh, since October 2013. Additionally, he holds the position of Joint Secretary at The Bangladesh Society for Biochemistry and Molecular Biology, Bangladesh, a role he has fulfilled since 2016. His dedication to education is evident in his role as a Student Advisor at the Department of Biochemistry and Molecular Biology, University of Dhaka, Bangladesh, from December 2010 to 2018. Prof. AHM Nurun Nabi’s contributions extend internationally, as he serves as an Honorary Visiting Professor at the Faculty of Applied Biological Sciences, Gifu University, Japan, a position he has held since April 2014. Prior to his current roles, he served as an Associate Professor in the Department of Biochemistry and Molecular Biology at the University of Dhaka from June 2011 to October 09, 2013. He also has experience as a Visiting Associate Professor at the Faculty of Applied Biological Sciences, Gifu University, Japan, from October 2009 to October 2010. His academic journey began as an Assistant Professor at the Department of Biochemistry and Molecular Biology, University of Dhaka, Bangladesh, from August 2006 to June 2011. Before that, he served as a Lecturer in the same department from March 2001 to July 2006. Additionally, he has contributed as Honorary Teaching Staff at the Department of Genetic Engineering and Biotechnology, University of Dhaka, Bangladesh, from January 2007 to June 2007.

Awards:

Prof. AHM Nurun Nabi has been recognized for his academic excellence and research contributions through various prestigious awards and scholarships. He received Merit Scholarships from the People’s Republic of Bangladesh for the periods 1990-92 and 1992-95, highlighting his exceptional academic performance. His pursuit of higher education was further supported by a Ph.D. Scholarship awarded by the Japan Government, which enabled him to conduct advanced research in biochemistry and molecular biology at the laboratory of Animal Biochemistry, United Graduate School of Agricultural Science, Gifu University, Japan, from 2003 to 2006. After completing his Ph.D., he was awarded a JSPS Postdoctoral Fellowship by the Japan Society for Promotion of Science, which allowed him to continue his research in Japan from 2007 to 2009, further enhancing his expertise in the field. In recognition of his contributions to academia, he was awarded a Fellowship from the Japan Student Service Organization (JASSO) in 2018, underscoring his commitment to academic excellence and research. These awards and scholarships reflect Prof. AHM Nurun Nabi’s dedication to advancing knowledge in biochemistry and molecular biology.

Research Experience:

During his Post-doctoral Research Fellowship, Prof. AHM Nurun Nabi conducted research focusing on in vitro protein expression, protein-protein interactions using Nanobiotechnology techniques, and protein purification. He also gained expertise in cell culture techniques, including troubleshooting, and studied angiogenesis. His primary research interests centered on the functional studies of Renin, Prorenin, and (Pro)renin receptors, with a particular focus on the binding mechanisms of renin and prorenin to (pro)renin receptors. Additionally, he has extensive experience in protein purification, cell culture, and the expression of specific genes for functional studies on the cell membrane. This experience has provided him with a comprehensive understanding of cellular processes and molecular interactions. Prof. AHM Nurun Nabi’s research also extends to public health issues. He conducted research to determine the health status, including biochemical and cellular conditions, of garage workers. His work aimed to raise awareness among workers regarding possible health hazards associated with working in such environments. Furthermore, he has conducted research on human samples collected from arsenic-endemic regions. His research focused on the nutritional, biochemical, and immunological aspects of arsenic toxicity in the Bangladeshi population chronically exposed to arsenic through drinking water. This research culminated in a thesis entitled “Immunological and Biochemical Investigations in Human Arsenic Toxicity,” submitted for the partial fulfillment of his M.Phil degree.

Prof. Ashish Kumar Tewari | Medicinal Chemistry | Best Research Award

Posted on by ScienceFather

Prof. Ashish Kumar Tewari | Medicinal Chemistry | Best Research Award

Professor at Medicinal Chemistry, Department of Chemistry Institute of Science Banaras Hindu University Varanasi 221005 INDIA

👨‍🎓He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Prof. Ashish Kumar Tewari holds a Ph.D. in Synthetic Organic Chemistry from Lucknow University, Lucknow, India, awarded in 2000. He completed his M.Sc. in Organic Chemistry from Kanpur University, with studies at F. G. College Raebareli, in 1993. His undergraduate degree, a B.Sc. in Chemistry and Physics, was obtained from Lucknow University (BSNV Degree College) in 1991.

Research Work:

Prof. Ashish Kumar Tewari is currently an Associate Professor in the Department of Chemistry at Banaras Hindu University, Varanasi, India. His research focuses on Molecular Recognition and Medicinal Chemistry. His work involves synthesizing bioactive molecules, flexible molecules with aromatic backbones, and foldamers to study aromatic interactions. Since approximately 20% of amino acids are aromatic, understanding aromatic interactions is crucial in drug-receptor interactions. His research group is actively involved in synthesizing pyrazole, imidazole, pyridine, and pyridazine systems, yielding interesting results such as solid-state eclipsed and staggered stacked conformations. Their work is reflected in their publications, with ongoing research yet to be published.

Post Doctoral Research Work:

During his postdoctoral research, Prof. Ashish Kumar Tewari worked at the Central Drug Research Institute (CDRI) in Lucknow, UP, India, as a CSIR Research Associate. His project focused on “Stereochemical control in aliphatic compounds by aromatic residues,” involving the synthesis of Pyrazolo[3,4-d]pyrimidine. This compound is isomeric to purine found in biological systems and serves as a model to study intra- and inter-molecular interactions important in drug-receptor interactions. He also worked as a Research Associate at the Indian Institute of Technology (IIT) in Mumbai, India, in the Department of Chemistry. His research there involved synthesizing monomers like triacytelene to prepare polydiacytelenes with aromatic backbones such as quinoline. This process included Suzuki coupling reaction followed by hydrolysis, leading to solid-state polymerization initiated thermally, photochemically, or by γ-irradiation. Recent interest in polydiacytelenes (PDAs) lies in their large and fast non-linear optical response, making them promising for applications in ultrafast optical signal processing.

Teaching Professional Work:

Prof. Ashish Kumar Tewari has held various positions in academia and the pharmaceutical industry. Since June 14, 2019, he has been serving as a Professor in the Department of Chemistry at Banaras Hindu University (BHU) in Varanasi, a Central University in India. Prior to this role, from June 14, 2016, to June 13, 2019, he was an Associate Professor in the same department, with a pay scale of Rs. 37400-67000/- plus AGP Rs. 9000. Before that, from June 14, 2004, to June 13, 2016, he served as an Assistant Professor (Senior Grade) at BHU, with a pay scale of Rs. 15600-39100/- plus AGP Rs. 7000. In these academic positions, his responsibilities included teaching undergraduate (UG) and postgraduate (PG) classes, as well as conducting research. Prior to his academic career, from September 3, 2003, to June 11, 2004, he worked as a Research Scientist at Lupin Research Park, a pharmaceutical industry research center, where he was involved in research activities.

Publications:

  1. Relationship between structure and inhibition behaviour of quinolinium salts for mild steel corrosion: Experimental and theoretical approach
    • Authors: MMS Punita Mourya, Praveen Singh, A.K. Tewari, R.B. Rastogi
    • Journal: Corrosion Science
    • Volume: 95
    • Pages: 71-87
    • Year: 2015
    • Citations: 195
  2. Synthesis and anti-inflammatory activities of N4, N5-disubstituted-3-methyl-1H-pyrazolo [3, 4-c] pyridazines
    • Authors: AK Tewari, A Mishra
    • Journal: Bioorganic & medicinal chemistry
    • Volume: 9
    • Issue: 3
    • Pages: 715-718
    • Year: 2001
    • Citations: 188
  3. Emerging trends in molecular recognition: utility of weak aromatic interactions
    • Authors: AK Tewari, R Dubey
    • Journal: Bioorganic & Medicinal Chemistry
    • Volume: 16
    • Issue: 1
    • Pages: 126-143
    • Year: 2008
    • Citations: 139
  4. Synthesis and antiviral activities of N-substituted-2-substituted-benzimidazole derivatives
    • Authors: AK Tewari, A Mishra
    • Source: CSIR
    • Year: 2006
    • Citations: 132
  5. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents
    • Authors: AK Tewari, VP Singh, P Yadav, G Gupta, A Singh, RK Goel, P Shinde, …
    • Journal: Bioorganic chemistry
    • Volume: 56
    • Pages: 8-15
    • Year: 2014
    • Citations: 94
  6. Design, synthesis, docking and anti-inflammatory evaluation of novel series of benzofuran based prodrugs
    • Authors: P Yadav, P Singh, AK Tewari
    • Journal: Bioorganic & medicinal chemistry letters
    • Volume: 24
    • Issue: 10
    • Pages: 2251-2255
    • Year: 2014
    • Citations: 82
  7. Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity
    • Authors: AK Tewari, P Srivastava, VP Singh, A Singh, RK Goel, CG Mohan
    • Journal: Chemical and Pharmaceutical Bulletin
    • Volume: 58
    • Issue: 5
    • Pages: 634-638
    • Year: 2010
    • Citations: 71
  8. Quantum chemical calculation studies for interactions of antiwear lubricant additives with metal surfaces
    • Authors: V Jaiswal, RB Rastogi, JL Maurya, P Singh, AK Tewari
    • Journal: RSC Advances
    • Volume: 4
    • Issue: 26
    • Pages: 13438-13445
    • Year: 2014
    • Citations: 35
  9. Docking, synthesis and evaluation of antioxidant activity of 2, 4, 5-triaryl imidazole
    • Authors: P Singh, R Kumar, S Tiwari, RS Khanna, AK Tewari, HD Khanna
    • Journal: Clin. Med. Biochem. Open Access
    • Volume: 1
    • Pages: 105
    • Year: 2015
    • Citations: 34
  10. Cascade synthesis of 2-pyridones using acrylamides and ketones
    • Authors: SK Rai, S Khanam, RS Khanna, AK Tewari
    • Journal: RSC Advances
    • Volume: 4
    • Issue: 83
    • Pages: 44141-44145
    • Year: 2014
    • Citations: 30

 

 

Dr. Shaymaa Kassab | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

Dr. Shaymaa Kassab : Leading Researcher in Medicinal Chemistry

Associate Professor of Medicinal Chemistry , Damanhour university, Egypt

She remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 She successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

B.Sc. in Pharmaceutical Sciences (1997-2002) from the Faculty of Pharmacy, Helwan University, Cairo, Egypt. M.Sc. in Pharmaceutical Chemistry (2002-2006) with a thesis on “Synthesis of Some Novel Glycosides of Expected Chemotherapeutic Activity” from the Faculty of Pharmacy, Helwan University, Egypt. Ph.D. in Pharmaceutical Chemistry (2007-2009) with a dissertation on “Synthesis of Certain Indole Derivatives of Expected Biological Activity” from the Faculty of Pharmacy, Cairo University, Egypt.

Skills:

Computational Chemistry: Proficient in using Molsoft ICM 3.4-8c, MOE, LeadiT, and SeeSAR 9 programs for docking flexible ligands and molecularly edited compounds into rigid proteins on the Windows operating system. Spectroscopy: Skilled in operating Nicolette FT/IR and Shimadzu spectrophotometers. Purification Systems: Experienced in operating the CombiFlash® Automated purification system. NMR Spectroscopy: Proficient in operating automated Bruker 400 MHz NMR and Varian NMR 400 spectrophotometers. Mass Spectrometry: Capable in operating the Amazon Ion trap ESI Mass Spectrophotometer.

Shaymaa Kassab ‘s citation metrics and indices from Google Scholar are as follows:

  • Cited by: All: 252, Since 2018: 221
  • Citations: 252 (All), 221 (Since 2018)
  • h-index: 9 (All), 9  (Since 2018)
  • i10-index: 9 (All), 9 (Since 2018)

These metrics showcase the impact of Kassab ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Academic Experience:

2002-2007: Teaching Assistant (B.Sc.) for practical sessions of Physical, Organic, and Pharmaceutical Chemistry courses at the Faculty of Pharmacy, Misr International University. 2007-2009: Teaching Assistant (M.Sc.) of Pharmaceutical Chemistry at the Faculty of Pharmacy, Misr International University. Address: Department of Pharmaceutical Chemistry, 425 El-Nargess Buildings, North Teseen St. (3rd Floor, Apt 8), New Cairo 11835, Faculty of Pharmacy, Damanhour Univ., Cairo, Egypt. Home Address: Galal Koreitam Square, Damanhour City 27. Contact Information: Mobile: +20-100-5267-570, Zip Code: 22516, Tel.: +20(45)3368069, Fax: +20(45)3368069, Email: shaymaakassab@yahoo.com, shaymaa.kassab@pharm.dmu.edu.eg. 2009-2011: Assistant Professor of Medicinal Chemistry, Supervisor of practical Pharmaceutical Chemistry courses at the Faculty of Pharmacy, Misr International University. Executive member in the Faculty’s Curriculum Committee and Exam Assessment and Examination Control Committee. 2010-2014: Lectured pharmacy students in Pharmaceutical Chemistry and Drug Design courses. Supervised one Master’s thesis entitled “Molecular design and synthesis of histone deacetylase inhibitors as antineoplastic agents,” which was awarded the degree.

Research Activities:

2014: Visiting Scholar at the University of Maryland in Baltimore, School of Pharmacy – Pharmaceutical Sciences Department, via a personal grant. 2016: Visiting Scholar at Virginia Commonwealth University, School of Pharmacy – Medicinal Chemistry Department, via a scientific mission offered by the Cultural Affairs and Missions Sector of the Ministry of Higher Education in Egypt. 2016: Visiting Scholar at Texas A&M University, College of Pharmacy – Pharmaceutical Sciences Department, via a scientific mission offered by the Cultural Affairs and Missions Sector of the Ministry of Higher Education in Egypt. 2017: Certified Outstanding Reviewer of the European Journal of Medicinal Chemistry.

Publication:

Design, synthesis, biological evaluation and docking studies of new 3-(4, 5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15 …

  • Published in Energy in 2018 with 43 citations.

Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities

  • Published in Energy in 2017 with 33 citations.

Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents

  • Published in Energy in 2014 with 32 citations.

Synthesis of 1H-Indole-2,3-Dione-3-Thiosemicarbazone Ribonucleosides as Antibacterial Agents

  • Published in Energy in 2010 with 28 citations.

Base-catalyzed one-step synthesis of 5, 7-disubstituted-1, 2, 4-triazolo [1, 5-a] pyrimidines

  • Published in Energy in 2016 with 24 citations.

A promising anti-cancer and anti-oxidant agents based on the pyrrole and fused pyrrole: synthesis, docking studies and biological evaluation

  • Published in Energy in 2015 with 21 citations.

 

Assoc Prof Dr. Mo’tasem Alsmadi | Biopharmaceutics

Posted on by ScienceFather
Assoc Prof Dr. Mo’tasem Alsmadi : Leading Researcher in Biopharmaceutics by Best Researcher Award

Associate Professor at Biopharmaceutics, Jordan University of Science & Technology, Jordan

Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Dr. Motasem Alsmadi is an Associate Professor of Biopharmaceutics and Pharmacokinetics with a joint appointment between the Nanotechnology Institute and the Pharmaceutical Technology Department at Jordan University of Science and Technology (J.U.S.T). He earned his BSc in Pharmacy, ranking first in his class, from J.U.S.T in 2009. Subsequently, he pursued graduate studies in Pharmaceutical Technology at The University of Iowa, completing his Ph.D. in December 2014. Afterward, he worked as an Assistant Professor of Pharmaceutical Technology at the Pharmacy School at J.U.S.T until September 2020, during which time he also served as an Assistant Dean at the Pharmacy School and the Graduate Studies School.

In September 2020, Dr. Alsmadi was promoted to an Associate Professor, and in January 2023, he was appointed as a Joint Professor in the Nanotechnology Institute. In this capacity, he taught graduate-level courses and supervised master’s students at the Nanotechnology Institute, in addition to his involvement in teaching undergraduate (B.Sc and Pharm D.) and graduate (MSc and Ph.D.) courses and supervising master’s students at the Pharmacy School. Dr. Alsmadi also served as a member of the JFDA Bioavailability and Bioequivalence Committee for two years (10/2019-10/2021) as part of his national service.

Academic/Professional Particulars:

Dr. Motasem Alsmadi specializes in Pharmaceutics/Biopharmaceutics and Pharmacokinetics, as well as Nanomedicine and in vivo safety and toxicokinetics of drug delivery systems. His academic qualifications include a Ph.D. in Pharmaceutics from the University of Iowa, USA, awarded in 2014. His dissertation was titled “Physiologically based pharmacokinetic (PBPK) model of Ivermectin (IVM),” and he achieved a GPA of 3.84. Dr. Alsmadi also holds a BSc in Pharmacy from Jordan University of Science and Technology, Jordan, awarded in 2008, where he ranked 1st in his batch. In terms of academic honors and awards, Dr. Alsmadi ranked 1st in the 2003 batch of BSc. in Pharmacy at Jordan University of Science and Technology from 2003 to 2008.

Mo’tasem Alsmadi ‘s citation metrics and indices from Google Scholar are as follows:

  • Cited by: All: 208, Since 2018: 208
  • Citations: 208 (All), 208 (Since 2018)
  • h-index: 9 (All), 9 (Since 2018)
  • i10-index: 7 (All), 7 (Since 2018)

These metrics showcase the impact of Alsmadi ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Research:

Dr. Motasem Alsmadi’s research interests include Physiologically-based Pharmacokinetics, Biopharmaceutics and Pharmacokinetics, and Nanomedicine, with a focus on in vivo safety and toxicokinetics of drug delivery systems. In terms of publications and citations, he has authored 17 articles in international refereed journals and presented 2 conference papers. His work has garnered 147 citations on Google Scholar. Dr. Alsmadi has also been involved in securing research grants, including the Local University Fund for Master’s Thesis, where he serves as the Principal Investigator for the project “Formulation and evaluation of oral administration of cilnidipine nanocrystals for treatment of Hypertension diseases by enhancing solubility and dissolution rate” at Jordan University of Science and Technology (07/2023 – Present), with a funding of USD 7,700. Additionally, he has been a Co-Investigator for another project titled “Physiologically-Based Pharmacokinetics of a Novel Hydroxychloroquine Formulation Prepared Using Supercritical Fluid Technology for Pulmonary Administration” at Jordan University of Science and Technology (08/2021 – 01/2023), with a funding of USD 8,000.

Teaching:

Dr. Motasem Alsmadi has taught several courses, including Nano 700: Introduction to Nanoscience and Nanotechnology (taught once, excellent evaluation), Phar456: Bio Pharmaceutics and Pharmacokinetics (taught fourteen times, excellent evaluations), Phar 553: Clinical Pharmacokinetics (For Pharm D Students) (taught fifteen times, excellent evaluations), Phar401: Pharmaceutical Practical Training (taught three times, excellent evaluations), Phar 402: Community Pharmacy (For Pharm.D Students) (taught twice, excellent evaluations), and Phar 351: Pharmaceutics 1 (taught once, excellent evaluation). This demonstrates Dr. Alsmadi’s extensive experience in teaching a variety of pharmaceutical and pharmacokinetics courses, consistently earning high evaluations from his students.

Publications:

Preparation of hybrid alginate-chitosan aerogel as potential carriers for pulmonary drug delivery

  • Published in Energy in 2020 with 38 citations.

Development, In Vitro Characterization, and In Vivo Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment

  • Published in Energy in 2020 with 34 citations.

Enhancement of the dissolution and bioavailability from freeze-dried powder of a hypocholesterolemic drug in the presence of Soluplus

  • Published in Energy in 2018 with 18 citations.

Pharmacy education in Jordan: updates

  • Published in Energy in 2017 with 17 citations.

Optimization of drugs pharmacotherapy during pregnancy using physiologically based pharmacokinetic models-an update

  • Published in Energy in 2018 with 14 citations.

Sublingual spray drug delivery of ketorolac-loaded chitosan nanoparticles

  • Published in Energy in 2018 with 14 citations.

 

Assist Prof Dr. Omaish Alqahtani | Pharmacognosy

Posted on by ScienceFather
🎉🏆 Congratulations,Assist Prof Dr. Omaish Alqahtani, on Your Outstanding Achievement as the Best Researcher! 🏆🎉
Assist Prof Dr. Omaish  Alqahtani : Leading Researcher in Pharmacognosy

Congratulations, Prof Dr. Omaish  Alqahtani, on winning the esteemed Best Researcher Award from Sciencefather! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Assist Prof Dr. Omaish Alqahtani, a distinguished academic and researcher in the field of renewable energy, holds a Assistant professor in Pharmacognosy from Najran University, Saudi Arabia. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Experiences

❖ Assistant Professor (2022 – present)

  • College of Pharmacy, Najran University, Najran, Saudi Arabia

❖ Lecturer (2017 – 2022)

  • College of Pharmacy, Najran University, Najran, Saudi Arabia

❖ Teaching Assistant (2011 – 2017)

  • College of Pharmacy, Najran University, Najran, Saudi Arabia

❖ Pharmacist (10/2010 – 1/2011)

  • King Fahad Central Hospital, Jazan, Saudi Arabia

Committee Memberships

❖ Head of the Teaching and Learning Unit (2022 – present)

❖ Head of the E-Learning Unit (2022 – present)

❖ Member of the Annual Report Committee (2022 – present)

❖ Member of the Field Training and Alumni Unit (2021 – present)

❖ Head of the Training and Scholarship Unit (2021 – 2023)

❖ Member of the Scientific Research Unit (2021 – 2023)

❖ Member of the Student Activities Unit (2022 – 2023)

Teaching Experiences

  • Recent Approaches in Medicinal plants analysis.
  • Herbal and Alternative Medicine.
  • Pharmacognosy (2).
  • Pharmacognosy (1) – Practical.

Education

❖ PhD in Pharmacognosy (2021)

  • School of Pharmacy, University College London, London, United Kingdom.

❖ MSc in Pharmacognosy (2015)

  • School of Pharmacy, University College London, London, United Kingdom.

❖ BSc in Pharmaceutical Sciences (2010)

  • College of Pharmacy, King Khalid University, Abha, Saudi Arabia.

Scientific Societies

❖ Member of the American Society of Pharmacognosy.

❖ Member of the Society of Medicinal Plant and Natural Products.

❖ Member of the Phytochemical Society of Europe.

Research Interest

❖ Discovering novel bioactive compounds from plants and bacteria.

Research List

  1. Design, Characterization, and Antimicrobial Evaluation of Copper Nanoparticles Utilizing Tamarixinin, an Ellagitannin from Galls of Tamarix aphylla.
  2. Phytochemistry, anti-diabetic and antioxidant potentials of Allium consanguineum Kunth.
  3. Synergistic Effect between Amoxicillin and Zinc Oxide Nanoparticles Reduced by Oak Gall Extract Against Helicobacter pylori.
  4. In Vitro Antibacterial Activity of Green Synthesized Silver Nanoparticles Using Azadirachta indica Aqueous Leaf Extract against MDR Pathogens.
  5. Characterization and isolation of the major biologically active metabolites isolated from Ficus retusa and their synergistic effect with Tetracycline against certain pathogenic-resistant Bacteria.
  6. The Biosynthesized Zinc Oxide Nanoparticles’ Antiviral Activity in Combination with Pelargonium zonale Extract against the Human Corona 229E Virus.
  7. Human Lung Cancer (A549) Cell Line Cytotoxicity and Anti-Leishmania major Activity of Carissa macrocarpa Leaves: A Study Supported by UPLCESI-MS/MS Metabolites Profiling and Molecular Docking.
  8. Phytochemical fingerprint and biological activities of three Malaysian Ficus Deltoidea Cultivars.
  9. Production of antibacterial compounds using Bacillus spp. isolated from thermal springs in Saudi Arabia.
  10. Quantitative-HPLC-DAD polyphenols analysis, anxiolytic and cognition enhancing potentials of Sorbaria tomentosa Lindl. Rehder.
  11. Process optimization, antioxidant, antibacterial, drug adjuvant properties of bioactive keratin microparticles derived from porcupine (Hystrix indica) quills.
  12. Nutritional, Antioxidant, Antimicrobial, and Anticholinesterase Properties of Phyllanthus emblica: A Study Supported by Spectroscopic and Computational Investigations.